Metastatic basal cell carcinoma: report of two cases and literature review.

Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
Journal of Cutaneous Maedicine and Surgery (Impact Factor: 0.71). 02/2005; 9(1):10-5. DOI: 10.1007/s10227-005-0027-1
Source: PubMed

ABSTRACT Metastatic basal cell carcinoma (MBCC) is defined as primary cutaneous basal cell carcinoma (BCC) that spreads to distant sites as histologically similar metastatic deposits of BCC. There are less than 300 reported cases of MBCC in the literature.
This article examines two cases of MBCC and provides a literature review of risk factors inherent in epidemiology, patient demographics, and the clinicohistopathological characteristics of primary and metastatic BCC lesions.
MBCC is a rare complication of BCC with high morbidity and mortality rates. Patients with MBCC often begin with long-standing primary BCC lesions that are either large or recurrent after treatment. Cases of MBCC have a higher incidence of the more aggressive histologic patterns (morpheic, infiltrating, metatypical, and basosquamous). Perineural space invasion may be an indicator of aggressive disease. Metastases often involve regional lymph nodes, lungs, bone, and skin.
These case reports and review provide important diagnostic and management considerations for primary BCC and MBCC. Early intervention with aggressive treatment measures may improve the prognosis and survival of MBCC patients.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of nonmelanoma skin cancer (NMSC) continues to rise, partly because of aging, the frequency of early childhood sunburns, and sporadic extreme recreational sun exposure. A nonsurgical approach to selected cutaneous malignancy could possibly reduce the cost as well as morbidity of surgical treatment for NMSC. There has been growing interest in isolating compounds that could suppress or reverse the biochemical changes necessary for cutaneous malignancies to progress by pharmacologic intervention. By targeting diverse pathways recognized as important in the pathogenesis of nonmelanoma skin cancers, a combination approach with multiple agents or addition of chemopreventative agents to topical sunscreens may offer the potential for novel and synergistic therapies in treating nonmelanoma skin cancer. This preliminary information will expand to include more therapeutic options for NMSC in the future.
    Indian Journal of Dermatology 01/2014; 59(6):531-546. DOI:10.4103/0019-5154.143503
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cutaneous malignancies, which commonly occur in the head and neck, are the most common cancers in the United States, and are composed primarily of the nonmelanoma skin cancers, basal cell carcinoma, and squamous cell carcinoma. Mohs micrographic surgery is often preferred over wide local excision for these nonmelanoma skin cancers of the head and neck. However, wide local excision is still the preferred method of primary resection for specific cutaneous malignancies of the head and neck. The purpose of this article is to describe the indications, preoperative workup, and technique for the primary surgical resection of cutaneous malignancies of the head and neck.
    Operative Techniques in Otolaryngology-Head and Neck Surgery 03/2013; 24(1):9-12. DOI:10.1016/j.otot.2013.02.003
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: ing it the most common cancer by incidence [1, 3]. The incidence of BCC has increased since the mid-2000s, and it is likely still un-derestimated because these tumors are not routinely included in cancer registries [2–4]. Despite the high incidence, BCC does not cause high mortality because it rarely metas-tasizes, although it does cause a substantial burden on health care [2, 3]. BCC most commonly occurs in elderly white persons in the seventh to eighth de-cades of life and affects men more than wom-en [2, 3, 5]. Sun exposure (to ultraviolet light, particularly in childhood) is the most impor-tant risk factor. Other risk factors include ex-posure to photosensitizing drugs and ionizing radiation, chronic arsenic exposure, and im-munosuppression [6–10]. BCC is also asso-ciated with certain inherited syndromes, the most common of which is basal cell nevus syndrome (Gorlin syndrome), in which mul-tiple BCCs occur early in life, and xeroderma pigmentosum [11, 12]. Gorlin syndrome is a rare autosomal dominant disorder character-ized by multiple anomalies, including macro-cephaly, keratocysts of the jaw, palmar and plantar pits, falx cerebri calcifications, rib anomalies, ovarian fibromas, medulloblasto-mas, and BCCs [11, 12]. Pathophysiologic and Clinical Features The pathogenesis of BCC involves al-terations in the patched-hedgehog signal pathway. Patched 1 protein (PTCH1) and smoothened protein (SMO) are components of the receptor complex for the sonic hedge- B asal cell carcinoma (BCC) is the most common carcinoma by in-cidence in the United States [1, 2]. It is an indolent primary cuta-neous neoplasm arising from the basal layer of epidermis. It is locally aggressive, may in-vade the skin and adjacent structures, includ-ing the muscles and bones, and has a low metastatic potential [1]. Surgery is the treat-ment of choice of primary BCC; chemother-apy is used for metastatic BCC. Imaging plays a major role in the staging and follow-up of metastatic BCC. Because of the low in-cidence of metastatic disease, the radiologic literature on BCC is retrospective and limit-ed. In this review, we comprehensively de-scribe the epidemiologic, pathophysiologic, and clinical features, diagnostic workup, staging, and management of BCC with a fo-cus on the role of imaging. Epidemiology BCC is grouped along with squamous cell carcinoma as nonmelanoma skin cancer (NMSC). NMSCs are the most common can-cers to occur in the United States. Although the precise incidence is difficult to estimate because cancer registries are not required to reported these tumors, one report estimat-ed an incidence of 3.5 million in the Unit-ed States in 2006 [2]. Similarly, data from the National Cancer Intelligence Network in the United Kingdom and Ireland revealed NMSC to account for 20% of all new ma-lignancies and 90% of all skin cancers [3]. BCC represents 74–75% of NMSCs,
    American Journal of Roentgenology 02/2015; 204(2):132-140. DOI:10.2214/AJR.14.13160 · 2.74 Impact Factor